版本:
中国

BRIEF-Manitex Capital's affiliate, Valeo Pharma announces partnership for parkinson's disease treatment

April 11 Manitex Capital Inc:

* Manitex Capital Inc's affiliate, Valeo Pharma Inc, announces partnership for a parkinson's disease treatment

* Manitex Capital- entered into partnership with Zambon s.p.a. For exclusive Canadian rights to commercialize new parkinson's disease product Xadago

* Manitex Capital Inc says valeo pharma will pay zambon upfront, regulatory and commercial milestone payments as well as royalties on product sales

* Manitex Capital - under terms of deal, Valeo Pharma to be responsible for all regulatory, sales, marketing, quality, distribution activities in Canada

* Manitex Capital - agreement grants Valeo Pharma exclusive rights to commercialise Zambon's parkinson's disease product, licensed from Newron Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐